speb/financial-data huggingface dataset:
CRNT income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -1267000.00
CRNT income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -1267000.00
CRNT cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -1267000.00
CRNT income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -1267000.00
CRNT income_statement (quarterly, 2025-06-30) — Net Interest Income: -2896000.00
CRNT cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -4700000.00
CRNT income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -2896000.00
CRNT balance_sheet (quarterly, 2025-06-30) — Net PPE: 54714000.00
CRNT cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -3957000.00
CRNT cash_flow (quarterly, 2025-06-30) — Net Short Term Debt Issuance: -4700000.00
CRNT balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 138310000.00
CRNT balance_sheet (quarterly, 2025-06-30) — Non Current Pension And Other Postretirement Benefit Plans: 8661000.00
CRNT income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 6307000.00
CRNT income_statement (quarterly, 2025-06-30) — Normalized Income: -1106700.00
CRNT cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 10762000.00
CRNT cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 0.00
CRNT income_statement (quarterly, 2025-06-30) — Operating Income: 2446000.00
CRNT income_statement (quarterly, 2025-06-30) — Operating Revenue: 82262000.00
CRNT balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 89889969.00
CRNT balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 20500000.00
CRNT balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -7703000.00
CRNT income_statement (quarterly, 2025-06-30) — Other Gand A: 6940000.00
CRNT income_statement (quarterly, 2025-06-30) — Other Income Expense: -229000.00
CRNT balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 22421000.00
CRNT balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 859000.00
CRNT balance_sheet (quarterly, 2025-06-30) — Other Payable: 25453000.00
CRNT balance_sheet (quarterly, 2025-06-30) — Other Properties: 54714000.00
CRNT balance_sheet (quarterly, 2025-06-30) — Other Receivables: 20994000.00
CRNT balance_sheet (quarterly, 2025-06-30) — Payables: 99212000.00
CRNT balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 99212000.00
CRNT income_statement (quarterly, 2025-06-30) — Pretax Income: -679000.00
CRNT cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 143000.00
CRNT cash_flow (quarterly, 2025-06-30) — Purchase Of Business: 0.00
CRNT cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -3957000.00
CRNT balance_sheet (quarterly, 2025-06-30) — Raw Materials: 25784000.00
CRNT balance_sheet (quarterly, 2025-06-30) — Receivables: 145045000.00
CRNT income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 53822000.00
CRNT income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 3632000.00
CRNT cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -4700000.00
CRNT income_statement (quarterly, 2025-06-30) — Research And Development: 7332000.00
CRNT income_statement (quarterly, 2025-06-30) — Restructuring And Mergern Acquisition: 229000.00
CRNT balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -253372000.00
CRNT income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 11722000.00
CRNT income_statement (quarterly, 2025-06-30) — Selling General And Administration: 18662000.00
CRNT balance_sheet (quarterly, 2025-06-30) — Share Issued: 93371492.00
CRNT cash_flow (quarterly, 2025-06-30) — Short Term Debt Payments: -4700000.00
CRNT income_statement (quarterly, 2025-06-30) — Special Income Charges: -229000.00
CRNT cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 1549000.00
CRNT balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 171777000.00
CRNT balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 138310000.00
CRNT income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -68700.00
CRNT income_statement (quarterly, 2025-06-30) — Tax Provision: 588000.00
CRNT income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.30
CRNT balance_sheet (quarterly, 2025-06-30) — Total Assets: 328385000.00
CRNT balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 171777000.00
CRNT balance_sheet (quarterly, 2025-06-30) — Total Debt: 37551000.00
CRNT balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 171777000.00
CRNT income_statement (quarterly, 2025-06-30) — Total Expenses: 79816000.00
CRNT balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 156608000.00
CRNT balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 94180000.00
CRNT balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 30743000.00
CRNT income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 2217000.00
CRNT income_statement (quarterly, 2025-06-30) — Total Unusual Items: -229000.00
CRNT income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -229000.00
CRNT balance_sheet (quarterly, 2025-06-30) — Tradeand Other Payables Non Current: 8758000.00
CRNT balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 3481523.00
CRNT balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 20091000.00
CRNT balance_sheet (quarterly, 2025-06-30) — Work In Process: 989000.00
CRNT balance_sheet (quarterly, 2025-06-30) — Working Capital: 108340000.00
CRNT income_statement (quarterly, 2025-09-30) — +Operating Expense: 25577000.00
CRNT income_statement (quarterly, 2025-09-30) — +Total Revenue: 85484000.00
CRNT balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 69637000.00
CRNT balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 111954000.00
CRNT balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 453576000.00
CRNT income_statement (quarterly, 2025-09-30) — Basic Average Shares: 90296561.00
CRNT income_statement (quarterly, 2025-09-30) — Basic EPS: 0.00
CRNT cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 29216000.00
CRNT cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -4114000.00
CRNT cash_flow (quarterly, 2025-09-30) — Capital Expenditure Reported: -964000.00
CRNT balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 16614000.00
CRNT balance_sheet (quarterly, 2025-09-30) — Capital Stock: 234000.00
CRNT balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 42987000.00
CRNT balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 42987000.00
CRNT cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 10504000.00
CRNT cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -4114000.00
CRNT cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 7161000.00
CRNT cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -5233000.00
CRNT cash_flow (quarterly, 2025-09-30) — Change In Inventory: 1276000.00
CRNT cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: -942000.00
CRNT cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -810000.00
CRNT cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: -1243000.00
CRNT cash_flow (quarterly, 2025-09-30) — Change In Payable: -7591000.00
CRNT cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -7591000.00
CRNT cash_flow (quarterly, 2025-09-30) — Change In Receivables: 12130000.00
CRNT cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 2820000.00
CRNT cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: 12130000.00
CRNT cash_flow (quarterly, 2025-09-30) — Changes In Cash: 13551000.00
CRNT balance_sheet (quarterly, 2025-09-30) — Common Stock: 234000.00
CRNT balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 172114000.00
CRNT income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 56134000.00
CRNT balance_sheet (quarterly, 2025-09-30) — Current Assets: 235492000.00
CRNT balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 3731000.00
CRNT balance_sheet (quarterly, 2025-09-30) — Current Debt: 31000000.00
CRNT balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 34731000.00
CRNT balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 1906000.00
CRNT balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 1906000.00
CRNT balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 129800000.00
CRNT balance_sheet (quarterly, 2025-09-30) — Defined Pension Benefit: 963000.00
CRNT cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 3436000.00
CRNT cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 3436000.00
CRNT income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 91744069.00
CRNT income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.00
CRNT income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 28000.00
CRNT income_statement (quarterly, 2025-09-30) — EBIT: 3773000.00
CRNT income_statement (quarterly, 2025-09-30) — EBITDA: 7209000.00
CRNT cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: 220000.00
CRNT balance_sheet (quarterly, 2025-09-30) — Employee Benefits: 3283000.00
CRNT cash_flow (quarterly, 2025-09-30) — End Cash Position: 42987000.00
CRNT cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 10504000.00
CRNT cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 3047000.00
CRNT cash_flow (quarterly, 2025-09-30) — Gain Loss On Sale Of PPE: 15000.00
CRNT balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -8261000.00
CRNT income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 6013000.00
CRNT balance_sheet (quarterly, 2025-09-30) — Goodwill: 11046000.00
CRNT balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 33705000.00
CRNT balance_sheet (quarterly, 2025-09-30) — Gross PPE: 55900000.00
CRNT income_statement (quarterly, 2025-09-30) — Gross Profit: 29350000.00
CRNT income_statement (quarterly, 2025-09-30) — Interest Expense: 2976000.00
CRNT income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 2976000.00
CRNT balance_sheet (quarterly, 2025-09-30) — Inventory: 58420000.00
CRNT balance_sheet (quarterly, 2025-09-30) — Invested Capital: 203114000.00
CRNT cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -4114000.00
CRNT balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 12883000.00
CRNT balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 12883000.00
CRNT cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: 0.00
CRNT income_statement (quarterly, 2025-09-30) — Net Income: 28000.00
CRNT income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 28000.00
CRNT income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 28000.00
CRNT income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 28000.00
CRNT income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 28000.00
CRNT cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 28000.00
CRNT income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 28000.00
CRNT income_statement (quarterly, 2025-09-30) — Net Interest Income: -2976000.00
CRNT cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: 10500000.00
CRNT income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -2976000.00
CRNT balance_sheet (quarterly, 2025-09-30) — Net PPE: 55900000.00
CRNT cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -3150000.00
CRNT cash_flow (quarterly, 2025-09-30) — Net Short Term Debt Issuance: 10500000.00
CRNT balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 138409000.00
CRNT balance_sheet (quarterly, 2025-09-30) — Non Current Pension And Other Postretirement Benefit Plans: 3283000.00
CRNT income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 7229000.00
CRNT income_statement (quarterly, 2025-09-30) — Normalized Income: 42000.00
CRNT cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 7161000.00
CRNT cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 15000.00
CRNT income_statement (quarterly, 2025-09-30) — Operating Income: 3773000.00
CRNT income_statement (quarterly, 2025-09-30) — Operating Revenue: 85484000.00
CRNT balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 89889969.00
CRNT balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 31000000.00
CRNT balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -8261000.00
CRNT income_statement (quarterly, 2025-09-30) — Other Gand A: 6013000.00
CRNT income_statement (quarterly, 2025-09-30) — Other Income Expense: -20000.00
CRNT balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 22659000.00
CRNT balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 861000.00
CRNT balance_sheet (quarterly, 2025-09-30) — Other Payable: 23526000.00
CRNT balance_sheet (quarterly, 2025-09-30) — Other Properties: 55900000.00
CRNT balance_sheet (quarterly, 2025-09-30) — Other Receivables: 22131000.00
CRNT balance_sheet (quarterly, 2025-09-30) — Payables: 93163000.00
CRNT balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 93163000.00
CRNT income_statement (quarterly, 2025-09-30) — Pretax Income: 777000.00
CRNT cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 4000.00
CRNT cash_flow (quarterly, 2025-09-30) — Purchase Of Business: 0.00
CRNT cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -3150000.00
CRNT balance_sheet (quarterly, 2025-09-30) — Receivables: 134085000.00
CRNT income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 56134000.00
CRNT income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 3436000.00
CRNT income_statement (quarterly, 2025-09-30) — Research And Development: 6955000.00
CRNT income_statement (quarterly, 2025-09-30) — Restructuring And Mergern Acquisition: 20000.00
CRNT balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -253344000.00
CRNT income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 12609000.00
CRNT income_statement (quarterly, 2025-09-30) — Selling General And Administration: 18622000.00
CRNT balance_sheet (quarterly, 2025-09-30) — Share Issued: 89889969.00
CRNT income_statement (quarterly, 2025-09-30) — Special Income Charges: -20000.00
CRNT cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 862000.00
CRNT balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 172114000.00
CRNT balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 138409000.00
CRNT income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -6000.00
CRNT income_statement (quarterly, 2025-09-30) — Tax Provision: 749000.00
CRNT income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.30
CRNT balance_sheet (quarterly, 2025-09-30) — Total Assets: 326921000.00
CRNT balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 172114000.00
CRNT balance_sheet (quarterly, 2025-09-30) — Total Debt: 47614000.00
CRNT balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 172114000.00
CRNT income_statement (quarterly, 2025-09-30) — Total Expenses: 81711000.00
CRNT balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 154807000.00
CRNT balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 91429000.00
CRNT balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 25007000.00
CRNT income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 3753000.00
CRNT income_statement (quarterly, 2025-09-30) — Total Other Finance Cost: 2976000.00
CRNT income_statement (quarterly, 2025-09-30) — Total Unusual Items: -20000.00
CRNT income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -20000.00
CRNT balance_sheet (quarterly, 2025-09-30) — Tradeand Other Payables Non Current: 8841000.00
CRNT balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 20091000.00
CRNT balance_sheet (quarterly, 2025-09-30) — Working Capital: 105692000.00
CRNT income_statement (annual, 2025-12-31) — +Operating Expense: 103502000.00
CRNT income_statement (quarterly, 2025-12-31) — +Operating Expense: 25949000.00
CRNT income_statement (annual, 2025-12-31) — +Total Revenue: 338728000.00
CRNT income_statement (quarterly, 2025-12-31) — +Total Revenue: 82330000.00
CRNT balance_sheet (annual, 2025-12-31) — Accounts Payable: 70784000.00
CRNT balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 70784000.00
CRNT balance_sheet (annual, 2025-12-31) — Accounts Receivable: 99673000.00
CRNT balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 99673000.00
CRNT balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -152851000.00
CRNT balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -152851000.00
CRNT balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 454640000.00
CRNT balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 454640000.00
CRNT balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -14060000.00
CRNT balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -14060000.00
CRNT cash_flow (annual, 2025-12-31) — Amortization Cash Flow: 3485000.00
CRNT cash_flow (annual, 2025-12-31) — Amortization Of Intangibles: 3485000.00
CRNT income_statement (annual, 2025-12-31) — Basic Average Shares: 89787286.00
CRNT income_statement (quarterly, 2025-12-31) — Basic Average Shares: 90612915.00
CRNT income_statement (annual, 2025-12-31) — Basic EPS: -0.02
CRNT income_statement (quarterly, 2025-12-31) — Basic EPS: 0.00
CRNT cash_flow (annual, 2025-12-31) — Beginning Cash Position: 35311000.00
CRNT cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 42987000.00
CRNT cash_flow (annual, 2025-12-31) — Capital Expenditure: -17427000.00
CRNT cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -4176000.00
CRNT cash_flow (annual, 2025-12-31) — Capital Expenditure Reported: -3818000.00
CRNT cash_flow (quarterly, 2025-12-31) — Capital Expenditure Reported: -1143000.00
CRNT balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 17332000.00
CRNT balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 17332000.00
CRNT balance_sheet (annual, 2025-12-31) — Capital Stock: 234000.00
CRNT balance_sheet (quarterly, 2025-12-31) — Capital Stock: 234000.00
CRNT balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 38368000.00
CRNT balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 38368000.00
CRNT balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 38368000.00
CRNT balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 38368000.00
CRNT cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -5510000.00
CRNT cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -11965000.00
CRNT cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -23997000.00
CRNT cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -4176000.00
CRNT cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 31556000.00
CRNT cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 11023000.00
CRNT cash_flow (annual, 2025-12-31) — Change In Account Payable: -22103000.00
CRNT cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 1175000.00
CRNT cash_flow (annual, 2025-12-31) — Change In Inventory: -2128000.00
CRNT cash_flow (quarterly, 2025-12-31) — Change In Inventory: -3531000.00
CRNT cash_flow (annual, 2025-12-31) — Change In Other Current Assets: -4241000.00
CRNT cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: -3034000.00
CRNT cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -3005000.00
CRNT cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -1280000.00
CRNT cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -818000.00
CRNT cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: 512000.00
CRNT cash_flow (annual, 2025-12-31) — Change In Payable: -27191000.00
CRNT cash_flow (quarterly, 2025-12-31) — Change In Payable: 976000.00
CRNT cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -27191000.00
CRNT cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 976000.00
CRNT cash_flow (annual, 2025-12-31) — Change In Receivables: 52567000.00
CRNT cash_flow (quarterly, 2025-12-31) — Change In Receivables: 12275000.00
CRNT cash_flow (annual, 2025-12-31) — Change In Working Capital: 15184000.00
CRNT cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 5918000.00
CRNT cash_flow (annual, 2025-12-31) — Changes In Account Receivables: 52567000.00
CRNT cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: 12275000.00
CRNT cash_flow (annual, 2025-12-31) — Changes In Cash: 2049000.00
CRNT cash_flow (quarterly, 2025-12-31) — Changes In Cash: -5118000.00
CRNT balance_sheet (annual, 2025-12-31) — Common Stock: 234000.00
CRNT balance_sheet (quarterly, 2025-12-31) — Common Stock: 234000.00
CRNT balance_sheet (annual, 2025-12-31) — Common Stock Equity: 172752000.00
CRNT balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 172752000.00
CRNT income_statement (annual, 2025-12-31) — Cost Of Revenue: 224176000.00
CRNT income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 54667000.00
CRNT balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 15389000.00
CRNT balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 15389000.00
CRNT balance_sheet (annual, 2025-12-31) — Current Assets: 225204000.00
CRNT balance_sheet (quarterly, 2025-12-31) — Current Assets: 225204000.00
CRNT balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 4001000.00
CRNT balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 4001000.00
CRNT balance_sheet (annual, 2025-12-31) — Current Debt: 19000000.00
CRNT balance_sheet (quarterly, 2025-12-31) — Current Debt: 19000000.00
CRNT balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 23001000.00
CRNT balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 23001000.00
CRNT balance_sheet (annual, 2025-12-31) — Current Deferred Assets: 9001000.00
CRNT balance_sheet (quarterly, 2025-12-31) — Current Deferred Assets: 9001000.00
CRNT balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 6201000.00
CRNT balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 6201000.00
CRNT balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 6201000.00
CRNT balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 6201000.00
CRNT balance_sheet (annual, 2025-12-31) — Current Liabilities: 120227000.00
CRNT balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 120227000.00
CRNT balance_sheet (annual, 2025-12-31) — Current Provisions: 2077000.00
CRNT balance_sheet (quarterly, 2025-12-31) — Current Provisions: 2077000.00
CRNT balance_sheet (annual, 2025-12-31) — Defined Pension Benefit: 362000.00
CRNT balance_sheet (quarterly, 2025-12-31) — Defined Pension Benefit: 362000.00
CRNT cash_flow (annual, 2025-12-31) — Depreciation: 10842000.00
CRNT cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 14327000.00
CRNT cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 3927000.00
CRNT cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 14327000.00
CRNT cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 3927000.00
CRNT income_statement (annual, 2025-12-31) — Diluted Average Shares: 89787286.00
CRNT income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 92432382.00
CRNT income_statement (annual, 2025-12-31) — Diluted EPS: -0.02
CRNT income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.00
CRNT income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -2090000.00
CRNT income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 129000.00
CRNT income_statement (annual, 2025-12-31) — EBIT: 5742000.00
CRNT income_statement (quarterly, 2025-12-31) — EBIT: -3594000.00
CRNT income_statement (annual, 2025-12-31) — EBITDA: 20069000.00
CRNT income_statement (quarterly, 2025-12-31) — EBITDA: 333000.00
CRNT cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 1008000.00
CRNT cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 499000.00
CRNT balance_sheet (annual, 2025-12-31) — Employee Benefits: 2537000.00
CRNT balance_sheet (quarterly, 2025-12-31) — Employee Benefits: 2537000.00
CRNT cash_flow (annual, 2025-12-31) — End Cash Position: 38368000.00
CRNT cash_flow (quarterly, 2025-12-31) — End Cash Position: 38368000.00
CRNT cash_flow (annual, 2025-12-31) — Financing Cash Flow: -5510000.00
CRNT cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -11965000.00
CRNT balance_sheet (annual, 2025-12-31) — Finished Goods: 32890000.00
CRNT balance_sheet (quarterly, 2025-12-31) — Finished Goods: 32890000.00
CRNT cash_flow (annual, 2025-12-31) — Free Cash Flow: 14129000.00
CRNT cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 6847000.00
CRNT cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: 44000.00
CRNT cash_flow (quarterly, 2025-12-31) — Gain Loss On Sale Of PPE: 19000.00
CRNT income_statement (annual, 2025-12-31) — Gain On Sale Of Security: -3562000.00
CRNT balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -8816000.00
CRNT balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -8816000.00
CRNT income_statement (annual, 2025-12-31) — General And Administrative Expense: 24394000.00
CRNT income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 6005000.00
CRNT balance_sheet (annual, 2025-12-31) — Goodwill: 11007000.00
CRNT balance_sheet (quarterly, 2025-12-31) — Goodwill: 11007000.00
CRNT balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 34189000.00
CRNT balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 34189000.00
CRNT balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 113733000.00
CRNT balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 113733000.00
CRNT balance_sheet (annual, 2025-12-31) — Gross PPE: 209357000.00
CRNT balance_sheet (quarterly, 2025-12-31) — Gross PPE: 209357000.00
CRNT income_statement (annual, 2025-12-31) — Gross Profit: 114552000.00
CRNT income_statement (quarterly, 2025-12-31) — Gross Profit: 27663000.00
CRNT balance_sheet (annual, 2025-12-31) — Hedging Assets Current: 1240000.00
CRNT balance_sheet (quarterly, 2025-12-31) — Hedging Assets Current: 1240000.00
CRNT cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 2650000.00
CRNT income_statement (annual, 2025-12-31) — Interest Expense: 5034000.00
CRNT income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 5034000.00
CRNT income_statement (annual, 2025-12-31) — Interest Income: 246000.00
CRNT income_statement (annual, 2025-12-31) — Interest Income Non Operating: 246000.00
CRNT cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 3611000.00
CRNT balance_sheet (annual, 2025-12-31) — Inventory: 61587000.00
CRNT balance_sheet (quarterly, 2025-12-31) — Inventory: 61587000.00
CRNT balance_sheet (annual, 2025-12-31) — Invested Capital: 191752000.00
CRNT balance_sheet (quarterly, 2025-12-31) — Invested Capital: 191752000.00
CRNT cash_flow (annual, 2025-12-31) — Investing Cash Flow: -23997000.00
CRNT cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -4176000.00
CRNT balance_sheet (annual, 2025-12-31) — Leases: 3199000.00
CRNT balance_sheet (quarterly, 2025-12-31) — Leases: 3199000.00
CRNT balance_sheet (annual, 2025-12-31) — Line Of Credit: 19000000.00
CRNT balance_sheet (quarterly, 2025-12-31) — Line Of Credit: 19000000.00
CRNT balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 13331000.00
CRNT balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 13331000.00
CRNT balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 13331000.00
CRNT balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 13331000.00
CRNT balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 189604000.00
CRNT balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 189604000.00
CRNT cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: -6570000.00
CRNT cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: 0.00
CRNT income_statement (annual, 2025-12-31) — Net Income: -2090000.00
CRNT income_statement (quarterly, 2025-12-31) — Net Income: 129000.00
CRNT income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -2090000.00
CRNT income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 129000.00
CRNT income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -2090000.00
CRNT income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 129000.00
CRNT income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -2090000.00
CRNT income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 129000.00
CRNT income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -2090000.00
CRNT income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 129000.00
CRNT cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -2090000.00
CRNT cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 129000.00
CRNT income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -2090000.00
CRNT income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 129000.00
CRNT income_statement (annual, 2025-12-31) — Net Interest Income: -4971000.00
CRNT income_statement (quarterly, 2025-12-31) — Net Interest Income: -89000.00
CRNT cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -6200000.00
CRNT cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -12000000.00
CRNT income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -4971000.00
CRNT income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -89000.00
CRNT balance_sheet (annual, 2025-12-31) — Net PPE: 56506000.00
CRNT balance_sheet (quarterly, 2025-12-31) — Net PPE: 56506000.00
CRNT cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -13609000.00
CRNT cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -3033000.00
CRNT cash_flow (annual, 2025-12-31) — Net Short Term Debt Issuance: -6200000.00
CRNT cash_flow (quarterly, 2025-12-31) — Net Short Term Debt Issuance: -12000000.00
CRNT balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 138563000.00
CRNT balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 138563000.00
CRNT balance_sheet (annual, 2025-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 2537000.00
CRNT balance_sheet (quarterly, 2025-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 2537000.00
CRNT income_statement (annual, 2025-12-31) — Normalized EBITDA: 25440000.00
CRNT income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 1248000.00
CRNT income_statement (annual, 2025-12-31) — Normalized Income: 1669700.00
CRNT income_statement (quarterly, 2025-12-31) — Normalized Income: 769500.00
CRNT cash_flow (annual, 2025-12-31) — Operating Cash Flow: 31556000.00
CRNT cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 11023000.00
CRNT cash_flow (annual, 2025-12-31) — Operating Gains Losses: 44000.00
CRNT cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 19000.00
CRNT income_statement (annual, 2025-12-31) — Operating Income: 11050000.00
CRNT income_statement (quarterly, 2025-12-31) — Operating Income: 1714000.00
CRNT income_statement (annual, 2025-12-31) — Operating Revenue: 338728000.00
CRNT income_statement (quarterly, 2025-12-31) — Operating Revenue: 82330000.00
CRNT balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 88392925.00
CRNT balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 88392925.00
CRNT balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 195000.00
CRNT balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 195000.00
CRNT balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -8816000.00
CRNT balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -8816000.00
CRNT income_statement (annual, 2025-12-31) — Other Gand A: 24394000.00
CRNT income_statement (quarterly, 2025-12-31) — Other Gand A: 6005000.00
CRNT income_statement (annual, 2025-12-31) — Other Income Expense: -5371000.00
CRNT income_statement (quarterly, 2025-12-31) — Other Income Expense: -915000.00
CRNT balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 23182000.00
CRNT balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 23182000.00
CRNT balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 781000.00
CRNT balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 781000.00
CRNT balance_sheet (annual, 2025-12-31) — Other Payable: 2580000.00
CRNT balance_sheet (quarterly, 2025-12-31) — Other Payable: 2580000.00
CRNT balance_sheet (annual, 2025-12-31) — Other Properties: 16554000.00
CRNT balance_sheet (quarterly, 2025-12-31) — Other Properties: 16554000.00
CRNT balance_sheet (annual, 2025-12-31) — Other Receivables: 13801000.00
CRNT balance_sheet (quarterly, 2025-12-31) — Other Receivables: 13801000.00
CRNT balance_sheet (annual, 2025-12-31) — Payables: 73364000.00
CRNT balance_sheet (quarterly, 2025-12-31) — Payables: 73364000.00
CRNT balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 88753000.00
CRNT balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 88753000.00
CRNT balance_sheet (annual, 2025-12-31) — Prepaid Assets: 1534000.00
CRNT balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 1534000.00
CRNT income_statement (annual, 2025-12-31) — Pretax Income: 708000.00
CRNT income_statement (quarterly, 2025-12-31) — Pretax Income: 710000.00
CRNT cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 690000.00
CRNT cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 35000.00
CRNT balance_sheet (annual, 2025-12-31) — Properties: 0.00
CRNT balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
CRNT cash_flow (annual, 2025-12-31) — Purchase Of Business: -6570000.00
CRNT cash_flow (quarterly, 2025-12-31) — Purchase Of Business: 0.00
CRNT cash_flow (annual, 2025-12-31) — Purchase Of PPE: -13609000.00
CRNT cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -3033000.00
CRNT balance_sheet (annual, 2025-12-31) — Raw Materials: 28567000.00
CRNT balance_sheet (quarterly, 2025-12-31) — Raw Materials: 28567000.00
CRNT balance_sheet (annual, 2025-12-31) — Receivables: 113474000.00
CRNT balance_sheet (quarterly, 2025-12-31) — Receivables: 113474000.00
CRNT income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 224176000.00
CRNT income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 54667000.00
CRNT income_statement (annual, 2025-12-31) — Reconciled Depreciation: 14327000.00
CRNT income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 3927000.00
CRNT cash_flow (annual, 2025-12-31) — Repayment Of Debt: -6200000.00
CRNT income_statement (annual, 2025-12-31) — Research And Development: 30427000.00
CRNT income_statement (quarterly, 2025-12-31) — Research And Development: 7891000.00
CRNT income_statement (annual, 2025-12-31) — Restructuring And Mergern Acquisition: 1809000.00
CRNT income_statement (quarterly, 2025-12-31) — Restructuring And Mergern Acquisition: -2647000.00
CRNT balance_sheet (annual, 2025-12-31) — Retained Earnings: -253215000.00
CRNT balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -253215000.00
CRNT income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 48681000.00
CRNT income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 12053000.00
CRNT income_statement (annual, 2025-12-31) — Selling General And Administration: 73075000.00
CRNT income_statement (quarterly, 2025-12-31) — Selling General And Administration: 18058000.00
CRNT balance_sheet (annual, 2025-12-31) — Share Issued: 91874448.00
CRNT balance_sheet (quarterly, 2025-12-31) — Share Issued: 91874448.00
CRNT cash_flow (annual, 2025-12-31) — Short Term Debt Payments: -6200000.00
CRNT income_statement (annual, 2025-12-31) — Special Income Charges: -1809000.00
CRNT income_statement (quarterly, 2025-12-31) — Special Income Charges: 2647000.00
CRNT cash_flow (annual, 2025-12-31) — Stock Based Compensation: 4091000.00
CRNT cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 1030000.00
CRNT balance_sheet (annual, 2025-12-31) — Stockholders Equity: 172752000.00
CRNT balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 172752000.00
CRNT balance_sheet (annual, 2025-12-31) — Tangible Book Value: 138563000.00
CRNT balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 138563000.00
CRNT income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -1611300.00
CRNT income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -274500.00
CRNT income_statement (annual, 2025-12-31) — Tax Provision: 2798000.00
CRNT income_statement (quarterly, 2025-12-31) — Tax Provision: 581000.00
CRNT income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.30
CRNT income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.30
CRNT balance_sheet (annual, 2025-12-31) — Total Assets: 317042000.00
CRNT balance_sheet (quarterly, 2025-12-31) — Total Assets: 317042000.00
CRNT balance_sheet (annual, 2025-12-31) — Total Capitalization: 172752000.00
CRNT balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 172752000.00
CRNT balance_sheet (annual, 2025-12-31) — Total Debt: 36332000.00
CRNT balance_sheet (quarterly, 2025-12-31) — Total Debt: 36332000.00
CRNT balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 172752000.00
CRNT balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 172752000.00
CRNT income_statement (annual, 2025-12-31) — Total Expenses: 327678000.00
CRNT income_statement (quarterly, 2025-12-31) — Total Expenses: 80616000.00
CRNT balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 144290000.00
CRNT balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 144290000.00
CRNT balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 91838000.00
CRNT balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 91838000.00
CRNT balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 24063000.00
CRNT balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 24063000.00
CRNT income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 7246000.00
CRNT income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 2366000.00
CRNT income_statement (annual, 2025-12-31) — Total Other Finance Cost: 183000.00
CRNT income_statement (quarterly, 2025-12-31) — Total Other Finance Cost: -4699000.00
CRNT income_statement (annual, 2025-12-31) — Total Unusual Items: -5371000.00
CRNT income_statement (quarterly, 2025-12-31) — Total Unusual Items: -915000.00
CRNT income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -5371000.00
CRNT income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -915000.00
CRNT balance_sheet (annual, 2025-12-31) — Tradeand Other Payables Non Current: 8195000.00
CRNT balance_sheet (quarterly, 2025-12-31) — Tradeand Other Payables Non Current: 8195000.00
CRNT balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 3481523.00
CRNT balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 3481523.00
CRNT balance_sheet (annual, 2025-12-31) — Treasury Stock: 20091000.00
CRNT balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 20091000.00
CRNT balance_sheet (annual, 2025-12-31) — Work In Process: 130000.00
CRNT balance_sheet (quarterly, 2025-12-31) — Work In Process: 130000.00
CRNT balance_sheet (annual, 2025-12-31) — Working Capital: 104977000.00
CRNT balance_sheet (quarterly, 2025-12-31) — Working Capital: 104977000.00
CRNT income_statement (quarterly, 2026-03-31) — +Operating Expense: 27451000.00
CRNT income_statement (quarterly, 2026-03-31) — +Total Revenue: 85003000.00
CRNT balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 65576000.00
CRNT balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 94421000.00
CRNT balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 455626000.00
CRNT income_statement (quarterly, 2026-03-31) — Basic Average Shares: 90709210.00
CRNT income_statement (quarterly, 2026-03-31) — Basic EPS: -0.01
CRNT cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 38368000.00
CRNT cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -3745000.00
CRNT cash_flow (quarterly, 2026-03-31) — Capital Expenditure Reported: -1470000.00
CRNT balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 16467000.00
CRNT balance_sheet (quarterly, 2026-03-31) — Capital Stock: 234000.00
CRNT balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 39164000.00
CRNT balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 39164000.00
CRNT cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -1891000.00
CRNT cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -3745000.00
CRNT cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 6530000.00
CRNT cash_flow (quarterly, 2026-03-31) — Change In Account Payable: -6174000.00
CRNT cash_flow (quarterly, 2026-03-31) — Change In Inventory: 3830000.00
CRNT cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: 2169000.00
CRNT cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: -979000.00
CRNT cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: 376000.00
CRNT cash_flow (quarterly, 2026-03-31) — Change In Payable: -7220000.00
CRNT cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -7220000.00
CRNT cash_flow (quarterly, 2026-03-31) — Change In Receivables: 5301000.00
CRNT cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 3477000.00
CRNT cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: 5301000.00
CRNT cash_flow (quarterly, 2026-03-31) — Changes In Cash: 894000.00
CRNT balance_sheet (quarterly, 2026-03-31) — Common Stock: 234000.00
CRNT balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 171496000.00
CRNT income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 54927000.00
CRNT balance_sheet (quarterly, 2026-03-31) — Current Assets: 213845000.00
CRNT balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 3957000.00
CRNT balance_sheet (quarterly, 2026-03-31) — Current Debt: 17100000.00
CRNT balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 21057000.00
CRNT balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 2710000.00
CRNT balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 2710000.00
CRNT balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 112510000.00
CRNT balance_sheet (quarterly, 2026-03-31) — Defined Pension Benefit: 378000.00
CRNT cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 3434000.00
CRNT cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 3434000.00
CRNT income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 90709210.00
CRNT income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.01
CRNT income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -1343000.00
CRNT income_statement (quarterly, 2026-03-31) — EBIT: 2625000.00
CRNT income_statement (quarterly, 2026-03-31) — EBITDA: 6059000.00
CRNT cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -98000.00
CRNT balance_sheet (quarterly, 2026-03-31) — Employee Benefits: 2590000.00
CRNT cash_flow (quarterly, 2026-03-31) — End Cash Position: 39164000.00
CRNT cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -1891000.00
CRNT cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 2785000.00
CRNT cash_flow (quarterly, 2026-03-31) — Gain Loss On Sale Of PPE: 70000.00
CRNT balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -9715000.00
CRNT income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 5520000.00
CRNT balance_sheet (quarterly, 2026-03-31) — Goodwill: 11007000.00
CRNT balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 34874000.00
CRNT balance_sheet (quarterly, 2026-03-31) — Gross PPE: 57567000.00
CRNT income_statement (quarterly, 2026-03-31) — Gross Profit: 30076000.00
CRNT balance_sheet (quarterly, 2026-03-31) — Inventory: 56456000.00
CRNT balance_sheet (quarterly, 2026-03-31) — Invested Capital: 188596000.00
CRNT cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -3745000.00
CRNT balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 12510000.00
CRNT balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 12510000.00
CRNT cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -1900000.00
CRNT cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: 0.00
CRNT income_statement (quarterly, 2026-03-31) — Net Income: -1343000.00
CRNT income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -1343000.00
CRNT income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -1343000.00
CRNT income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -1343000.00
CRNT income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -1343000.00
CRNT cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -1343000.00
CRNT income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -1343000.00
CRNT income_statement (quarterly, 2026-03-31) — Net Interest Income: -2856000.00
CRNT cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -1900000.00
CRNT cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -1900000.00
CRNT income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -2856000.00
CRNT balance_sheet (quarterly, 2026-03-31) — Net PPE: 57567000.00
CRNT cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -2275000.00
CRNT balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 136622000.00
CRNT balance_sheet (quarterly, 2026-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 2590000.00
CRNT income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 6599000.00
CRNT income_statement (quarterly, 2026-03-31) — Normalized Income: -1019000.00
CRNT cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 6530000.00
CRNT cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 70000.00
CRNT income_statement (quarterly, 2026-03-31) — Operating Income: 2625000.00
CRNT income_statement (quarterly, 2026-03-31) — Operating Revenue: 85003000.00
CRNT balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 90876955.00
CRNT balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 17100000.00
CRNT balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -9715000.00
CRNT income_statement (quarterly, 2026-03-31) — Other Gand A: 5520000.00
CRNT income_statement (quarterly, 2026-03-31) — Other Income Expense: -540000.00